AstraZeneca PLC (AZN)
| Previous Close | 66.03 |
| Open | 65.68 |
| Bid | 65.24 x 800 |
| Ask | 65.25 x 1400 |
| Day's Range | 64.79 - 66.00 |
| 52 Week Range | 53.63 - 71.70 |
| Volume | |
| Avg. Volume | 6,477,188 |
| Market Cap | 202.166B |
| Beta (5Y Monthly) | 0.10 |
| PE Ratio (TTM) | 120.48 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 1.44 (2.15%) |
| Ex-Dividend Date | Feb 24, 2022 |
| 1y Target Est | N/A |
- Motley Fool
3 Unstoppable Stocks That Don't Care About the Bear Market
Whether it's thanks to a winning business model or timely good news, some companies are taking the bear market in stride, and some are even crushing it. Compared to the broader market's slump of around 5% in the last 12 months, AstraZeneca's (NASDAQ: AZN) stock has climbed 19%, making it a robust outperformer, to say the least. The company's success during the bear market is simply a matter of the strength of its drug development pipeline; with 184 projects in clinical trials and late-preclinical testing, it's among the largest in the world.
- Simply Wall St.
AstraZeneca (LON:AZN) Has Announced That It Will Be Increasing Its Dividend To $0.764
The board of AstraZeneca PLC ( LON:AZN ) has announced that it will be paying its dividend of $0.764 on the 12th of...
- Zacks
Moderna (MRNA) Beats on Q2 Earnings, Starts $3B Buyback Program
Moderna's (MRNA) earnings and sales beat expectations. The company also announces another $3-billion buyback program. Stock gains in pre-market.
